Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.48 - $4.28 $60,987 - $176,370
-41,208 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$4.21 - $14.79 $2,757 - $9,687
655 Added 1.62%
41,208 $200,000
Q4 2021

Feb 11, 2022

BUY
$14.78 - $24.4 $11,912 - $19,666
806 Added 2.03%
40,553 $601,000
Q3 2021

Nov 12, 2021

BUY
$17.25 - $26.63 $24,805 - $38,293
1,438 Added 3.75%
39,747 $858,000
Q2 2021

Aug 11, 2021

BUY
$16.31 - $23.64 $20,354 - $29,502
1,248 Added 3.37%
38,309 $628,000
Q1 2021

May 13, 2021

SELL
$22.43 - $44.27 $628 - $1,239
-28 Reduced 0.08%
37,061 $877,000
Q4 2020

Feb 09, 2021

SELL
$11.66 - $24.5 $21,209 - $44,565
-1,819 Reduced 4.68%
37,089 $884,000
Q3 2020

Nov 12, 2020

SELL
$9.27 - $13.14 $16,574 - $23,494
-1,788 Reduced 4.39%
38,908 $458,000
Q2 2020

Aug 12, 2020

BUY
$6.23 - $13.09 $56,792 - $119,328
9,116 Added 28.87%
40,696 $425,000
Q1 2020

May 06, 2020

SELL
$5.23 - $15.2 $653 - $1,900
-125 Reduced 0.39%
31,580 $226,000
Q4 2019

Feb 14, 2020

BUY
$12.58 - $15.97 $17,473 - $22,182
1,389 Added 4.58%
31,705 $425,000
Q3 2019

Nov 07, 2019

SELL
$10.73 - $17.33 $12,339 - $19,929
-1,150 Reduced 3.65%
30,316 $468,000
Q2 2019

Aug 12, 2019

SELL
$11.11 - $17.34 $310,691 - $484,913
-27,965 Reduced 47.05%
31,466 $415,000
Q1 2019

May 14, 2019

BUY
$11.69 - $19.44 $24,513 - $40,765
2,097 Added 3.66%
59,431 $1.05 Million
Q4 2018

Feb 11, 2019

SELL
$9.08 - $14.34 $81,266 - $128,343
-8,950 Reduced 13.5%
57,334 $657,000
Q3 2018

Nov 09, 2018

BUY
$12.83 - $16.45 $60,737 - $77,874
4,734 Added 7.69%
66,284 $0
Q2 2018

Aug 06, 2018

BUY
$14.04 - $20.28 $71,983 - $103,975
5,127 Added 9.09%
61,550 $932,000
Q1 2018

May 15, 2018

BUY
$12.67 - $24.69 $2,052 - $3,999
162 Added 0.29%
56,423 $763,000
Q4 2017

Feb 09, 2018

BUY
$18.81 - $30.33 $1.06 Million - $1.71 Million
56,261
56,261 $1.33 Million

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $585M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.